{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:36:04Z","timestamp":1781210164035,"version":"3.54.1"},"reference-count":136,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2025.13016","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T12:38:13Z","timestamp":1763123893000},"page":"1-17","source":"Crossref","is-referenced-by-count":2,"title":["Diagnosis and treatment of invasive fungal disease in children with hematological malignancies after chemotherapy: Challenges and strategies (Review)"],"prefix":"10.3892","volume":"31","author":[{"given":"Mingxin","family":"He","sequence":"first","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, Guangdong 518052, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[{"name":"Oncology Center, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430014, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Xian","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer, Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Guangdong 518116, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, Guangdong 518052, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"issue":"1084666","key":"key20251229141312_b1-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1084666","article-title":"Invasive fungal disease in COVID-19 patients: A single-center prospective observational study","volume":"10","author":"Adzic-Vukicevic","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"1435239","key":"key20251229141312_b2-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1435239","article-title":"A rare intestinal mucormycosis caused by Lichtheimia ramosa in a patient with diabetes: A case report","volume":"11","author":"Liu","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"117","key":"key20251229141312_b3-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12010117","article-title":"High-Risk neutropenic fever and invasive fungal diseases in patients with hematological malignancies","volume":"12","author":"Mori","year":"2024","journal-title":"Microorganisms"},{"key":"key20251229141312_b4-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s13277-014-2649-7","article-title":"Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: A multicenter, prospective, observational study in China","volume":"36","author":"Sun","year":"2015","journal-title":"Tumour Biol"},{"key":"key20251229141312_b5-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/cid\/ciae612","article-title":"Invasive fungal disease in patients undergoing allogeneic hematopoietic stem cell transplantation in China: A multicenter epidemiological study (CAESAR 2.0)","volume":"80","author":"Li","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"w14281","key":"key20251229141312_b6-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2016.14281","article-title":"Common invasive fungal diseases: An overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia","volume":"146","author":"Schmiedel","year":"2016","journal-title":"Swiss Med Wkly"},{"key":"key20251229141312_b7-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1111\/j.1469-0691.2008.01978.x","article-title":"Changing epidemiology of systemic fungal infections","volume":"14 (Suppl 4)","author":"Richardson","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"key20251229141312_b8-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijid.2013.11.016","article-title":"Colonic basidiobolomycosis in a child: Report of a culture-proven case","volume":"22","author":"Zabolinejad","year":"2014","journal-title":"Int J Infect Dis"},{"key":"key20251229141312_b9-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1093\/jpids\/pix054","article-title":"Role of molecular biomarkers in the diagnosis of invasive fungal diseases in children","volume":"6 (Suppl 1)","author":"Huppler","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key20251229141312_b10-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1093\/jpids\/piab036","article-title":"Prospective evaluation of galactomannan and (1\u21923) \u03b2-d-glucan assays as diagnostic tools for invasive fungal disease in children, adolescents, and young adults with acute myeloid leukemia receiving fungal prophylaxis","volume":"10","author":"Fisher","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"208","key":"key20251229141312_b11-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03099-w","article-title":"Clinical features of invasive fungal disease in children with no underlying disease","volume":"12","author":"Huang","year":"2022","journal-title":"Sci Rep"},{"issue":"518","key":"key20251229141312_b12-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00518","article-title":"Diagnostic approaches for invasive aspergillosis-specific considerations in the pediatric population","volume":"9","author":"Lehrnbecher","year":"2018","journal-title":"Front Microbiol"},{"issue":"375","key":"key20251229141312_b13-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030375","article-title":"Isavuconazole treatment for invasive fungal infections in pediatric patients","volume":"15","author":"Zimmermann","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"key20251229141312_b14-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/01.mph.0000155861.38641.ca","article-title":"Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution","volume":"27","author":"Rosen","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"key20251229141312_b15-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat Microbiol"},{"key":"key20251229141312_b16-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"776","DOI":"10.5858\/arpa.2016-0539-RA","article-title":"Validation of metagenomic next-generation sequencing tests for universal pathogen detection","volume":"141","author":"Schlaberg","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"1011723","key":"key20251229141312_b17-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1011723","article-title":"Metagenomics by next-generation sequencing (mNGS) in the etiological characterization of neonatal and pediatric sepsis: A systematic review","volume":"11","author":"Agudelo-P\u00e9rez","year":"2023","journal-title":"Front Pediatr"},{"issue":"552","key":"key20251229141312_b18-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06292-4","article-title":"Clinical application of cell-free next-generation sequencing for infectious diseases at a tertiary children's hospital","volume":"21","author":"Wilke","year":"2021","journal-title":"BMC Infect Dis"},{"key":"key20251229141312_b19-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1093\/jpids\/piad115","article-title":"Pipeline of novel antifungals for invasive fungal disease in transplant recipients: A pediatric perspective","volume":"13 (Suppl 1)","author":"Hsu","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1056489","key":"key20251229141312_b20-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1056489","article-title":"Fungal infections in pediatric patients with acute myeloid leukemia in a tertiary hospital","volume":"11","author":"\u00c1vila Montiel","year":"2023","journal-title":"Front Public Health"},{"issue":"e14399","key":"key20251229141312_b21-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14399","article-title":"Prospective evaluation of the fungitell\u00ae (1\u21923) beta-D-glucan assay as a diagnostic tool for invasive fungal disease in pediatric allogeneic hematopoietic cell transplantation: A report from the children's oncology group","volume":"27","author":"Otto","year":"2023","journal-title":"Pediatr Transplant"},{"key":"key20251229141312_b22-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jpeds.2021.05.016","article-title":"Invasive fungal infections in immunocompromised children: Novel insight following a national study","volume":"236","author":"Olivier-Gougenheim","year":"2021","journal-title":"J Pediatr"},{"key":"key20251229141312_b23-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/jpids\/pix030","article-title":"Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: A systematic review","volume":"7","author":"Fisher","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"e29275","key":"key20251229141312_b24-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29275","article-title":"Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10-year review","volume":"68","author":"Yeoh","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"key20251229141312_b25-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/pbc.23005","article-title":"Invasive fungal infections in pediatric oncology","volume":"56","author":"Mor","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"348","key":"key20251229141312_b26-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08314-9","article-title":"Changes in the epidemiology of invasive fungal disease in a Pediatric hematology and oncology unit: The relevance of breakthrough infections","volume":"23","author":"Calle-Miguel","year":"2023","journal-title":"BMC Infect Dis"},{"key":"key20251229141312_b27-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmii.2016.08.011","article-title":"Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan","volume":"51","author":"Lin","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"key20251229141312_b28-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"94","DOI":"10.4274\/tjh.galenos.2021.2021.0203","article-title":"Invasive fungal infections in children with leukemia: Clinical features and prognosis","volume":"39","author":"Sezgin Evim","year":"2022","journal-title":"Turk J Haematol"},{"key":"key20251229141312_b29-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4274\/tjh.2014.0035","article-title":"Management of invasive fungal infections in pediatric acute leukemia and the appropriate time for restarting chemotherapy","volume":"32","author":"T\u00fcfek\u00e7i","year":"2015","journal-title":"Turk J Haematol"},{"key":"key20251229141312_b30-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41375-022-01768-x","article-title":"Invasive fungal diseases impact on outcome of childhood ALL-an analysis of the international trial AIEOP-BFM ALL 2009","volume":"37","author":"Lehrnbecher","year":"2023","journal-title":"Leukemia"},{"key":"key20251229141312_b31-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"key20251229141312_b32-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/myc.13148","article-title":"Breakthrough invasive fungal infections: Who is at risk?","volume":"63","author":"Jenks","year":"2020","journal-title":"Mycoses"},{"issue":"347","key":"key20251229141312_b33-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/jof7050347","article-title":"Breakthrough invasive fungal infections in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Liberatore","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"key20251229141312_b34-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1111\/myc.12960","article-title":"Defining breakthrough invasive fungal infection-position paper of the mycoses study group education and research consortium and the European confederation of medical mycology","volume":"62","author":"Cornely","year":"2019","journal-title":"Mycoses"},{"key":"key20251229141312_b35-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jinf.2023.08.001","article-title":"European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study","volume":"87","author":"Arendrup","year":"2023","journal-title":"J Infect"},{"key":"key20251229141312_b36-ETM-31-1-13016","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.riam.2016.04.003","article-title":"Epidemiology, risk factors and in vitro susceptibility in candidaemia due to non-Candida albicans species","volume":"33","author":"Mar\u00edn Mart\u00ednez","year":"2016","journal-title":"Rev Iberoam Micol"},{"key":"key20251229141312_b37-ETM-31-1-13016","author":"Castagnola"},{"issue":"102804","key":"key20251229141312_b38-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2025.102804","article-title":"Epidemiology of invasive fungal diseases in patients with hematological malignancies and haematopoietic cell transplantation recipients: Systematic review and meta-analysis of trends over time","volume":"18","author":"Popova","year":"2025","journal-title":"J Infect Public Health"},{"key":"key20251229141312_b39-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1080\/14787210.2019.1626718","article-title":"The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantation","volume":"17","author":"Lehrnbecher","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key20251229141312_b40-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European conference on infections in leukaemia: 2020 Guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"issue":"e15186","key":"key20251229141312_b41-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15186","article-title":"Expert consensus on the relevance of intestinal microecology and hematopoietic stem cell transplantation","volume":"38","author":"Wang","year":"2024","journal-title":"Clin Transplant"},{"issue":"100719","key":"key20251229141312_b42-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2024.100719","article-title":"The epidemiology of invasive fungal infections in transplant recipients","volume":"47","author":"Elhaj Mahmoud","year":"2024","journal-title":"Biomed J"},{"key":"key20251229141312_b43-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/jpids\/pix046","article-title":"Epidemiology of invasive fungal disease in children","volume":"6 (Suppl 1)","author":"Pana","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key20251229141312_b44-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/jpids\/pix039","article-title":"International collaborative on contemporary epidemiology and diagnosis of invasive fungal disease in children","volume":"6 (Suppl 1)","author":"Steinbach","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"key20251229141312_b45-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/myc.12990","article-title":"Epidemiology and outcome of invasive fungal disease in children after hematopoietic cell transplantation or treated for malignancy: Impact of national programme of antifungal prophylaxis","volume":"62","author":"Czy\u017cewski","year":"2019","journal-title":"Mycoses"},{"key":"key20251229141312_b46-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00277-023-05509-7","article-title":"The indirect effects of CMV reactivation on patients following allogeneic hematopoietic stem cell transplantation: An evidence mapping","volume":"103","author":"Wu","year":"2024","journal-title":"Ann Hematol"},{"issue":"684147","key":"key20251229141312_b47-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.684147","article-title":"Modeling influencing factors in B-cell reconstitution after hematopoietic stem cell transplantation in children","volume":"12","author":"van der Maas","year":"2021","journal-title":"Front Immunol"},{"key":"key20251229141312_b48-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clim.2007.11.013","article-title":"Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation","volume":"127","author":"Marie-Cardine","year":"2008","journal-title":"Clin Immunol"},{"key":"key20251229141312_b49-ETM-31-1-13016","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.4049\/jimmunol.144.8.3028","article-title":"Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1- and IL-4-induced B cell activities in vitro","volume":"144","author":"Maliszewski","year":"1990","journal-title":"J Immunol"},{"key":"key20251229141312_b50-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.1128\/MCB.19.9.5969","article-title":"Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene","volume":"19","author":"Pan","year":"1999","journal-title":"Mol Cell Biol"},{"issue":"2071","key":"key20251229141312_b51-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37424-w","article-title":"Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells","volume":"14","author":"Inaba","year":"2023","journal-title":"Nat Commun"},{"issue":"1185597","key":"key20251229141312_b52-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1185597","article-title":"The NF\u03baB signaling system in the generation of B-cell subsets: from germinal center B cells to memory B cells and plasma cells","volume":"14","author":"Roy","year":"2023","journal-title":"Front Immunol"},{"issue":"848","key":"key20251229141312_b53-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/jof7100848","article-title":"Changing epidemiology of invasive fungal disease in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Puerta-Alcalde","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"681","key":"key20251229141312_b54-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00681","article-title":"Incidence and outcome of invasive fungal diseases in children with hematological malignancies and\/or allogeneic hematopoietic stem cell transplantation: Results of a prospective multicenter study","volume":"10","author":"Lehrnbecher","year":"2019","journal-title":"Front Microbiol"},{"key":"key20251229141312_b55-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/INF.0000000000004502","article-title":"Invasive candidiasis in pediatric hematologic malignancy: Increased risk of dissemination with Candida tropicalis","volume":"44","author":"Said","year":"2025","journal-title":"Pediatr Infect Dis J"},{"issue":"718","key":"key20251229141312_b56-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060718","article-title":"Diagnosis and treatment of invasive candidiasis","volume":"11","author":"Barantsevich","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"key20251229141312_b57-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11684-018-0641-0","article-title":"Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China assessment of antifungal therapy in hematological diseases (CAESAR) study","volume":"13","author":"Wang","year":"2019","journal-title":"Front Med"},{"key":"key20251229141312_b58-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.bbmt.2015.03.018","article-title":"Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: A multicenter prospective observational study","volume":"21","author":"Sun","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"key20251229141312_b59-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/MPH.0000000000001431","article-title":"Hepatosplenic fungal infections in children with leukemia-risk factors and outcome: A multicentric study","volume":"41","author":"Celkan","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"key20251229141312_b60-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.medcli.2024.01.045","article-title":"Invasive aspergillosis: A comprehensive review","volume":"163","author":"Machado","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"key20251229141312_b61-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11046-023-00727-z","article-title":"Treatment of invasive aspergillosis: How it's going, where it's heading","volume":"188","author":"Boyer","year":"2023","journal-title":"Mycopathologia"},{"key":"key20251229141312_b62-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.jaip.2019.02.041","article-title":"Spectrum of pulmonary aspergillosis in hyper-IgE syndrome with autosomal-dominant STAT3 deficiency","volume":"7","author":"Dur\u00e9ault","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"168","key":"key20251229141312_b63-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/jof7030168","article-title":"Central nervous system mold infections in children with hematological malignancies: Advances in diagnosis and treatment","volume":"7","author":"Luckowitsch","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"key20251229141312_b64-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"e1039","DOI":"10.1097\/MPH.0000000000002499","article-title":"Central nervous system fungal infections in children with leukemia and undergoing hematopoietic stem cell transplantation: A retrospective multicenter study","volume":"44","author":"Karaman","year":"2022","journal-title":"J Pediatr Hematol Oncol"},{"key":"key20251229141312_b65-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: From the imaging working group for the revision and update of the consensus definitions of fungal disease from the EORTC\/MSGERC","volume":"72 (Suppl 2)","author":"Alexander","year":"2021","journal-title":"Clin Infect Dis"},{"key":"key20251229141312_b66-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s10096-020-04054-9","article-title":"Clinical study on empirical and diagnostic-driven (pre-emptive) therapy of voriconazole in severe aplastic anaemia patients with invasive fungal disease after intensive immunosuppressive therapy","volume":"40","author":"Wu","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"42","key":"key20251229141312_b67-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00926-2","article-title":"Diagnosis of invasive fungal infections: challenges and recent developments","volume":"30","author":"Fang","year":"2023","journal-title":"J Biomed Sci"},{"key":"key20251229141312_b68-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/cid\/cir897","article-title":"\u03b2-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: A systematic review and meta-analysis of cohort studies from the third European conference on infections in leukemia (ECIL-3)","volume":"54","author":"Lamoth","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key20251229141312_b69-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11684-017-0601-0","article-title":"Epidemiology of fungal infections in China","volume":"12","author":"Chen","year":"2018","journal-title":"Front Med"},{"key":"key20251229141312_b70-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"e271","DOI":"10.1097\/MPH.0000000000001653","article-title":"Assessment of serum galactomannan test results of pediatric patients with hematologic malignancies according to consecutive positivity and threshold level in terms of invasive aspergillosis diagnosis: Cross-sectional research in a tertiary care hospital","volume":"42","author":"\u00c7a\u011flar","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"issue":"238","key":"key20251229141312_b71-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/jof7030238","article-title":"Diagnostic performance of (1\u21923)-\u03b2-D-glucan alone and in combination with Aspergillus PCR and galactomannan in serum of pediatric patients after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Springer","year":"2021","journal-title":"J Fungi (Basel)"},{"issue":"1262","key":"key20251229141312_b72-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/jof8121262","article-title":"Serum beta-D-glucan in the diagnosis of invasive fungal disease in neonates, children and adolescents: A critical analysis of current data","volume":"8","author":"Ferreras-Antolin","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"key20251229141312_b73-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/14787210.2019.1690455","article-title":"Diagnosis of invasive fungal disease in children: A narrative review","volume":"17","author":"Saffioti","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key20251229141312_b74-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12281-017-0274-9","article-title":"Progress in the diagnosis of invasive fungal disease in children","volume":"11","author":"Warris","year":"2017","journal-title":"Curr Fungal Infect Rep"},{"key":"key20251229141312_b75-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/bjh.16452","article-title":"Fungal infections in children with haematologic malignancies and stem cell transplant recipients","volume":"189","author":"Otto","year":"2020","journal-title":"Br J Haematol"},{"key":"key20251229141312_b76-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.3892\/etm.2017.5081","article-title":"Evaluation of the diagnostic performance of panfungal polymerase chain reaction assay in invasive fungal diseases","volume":"14","author":"Cao","year":"2017","journal-title":"Exp Ther Med"},{"key":"key20251229141312_b77-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/14737159.2022.2037423","article-title":"An overview of using fungal DNA for the diagnosis of invasive mycoses","volume":"22","author":"White","year":"2022","journal-title":"Expert Rev Mol Diagn"},{"key":"key20251229141312_b78-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/mmy\/myaa038","article-title":"Comparative accuracy of 1,3 beta-D glucan and galactomannan for diagnosis of invasive fungal infections in pediatric patients: A systematic review with meta-analysis","volume":"59","author":"Singh","year":"2021","journal-title":"Med Mycol"},{"issue":"1542922","key":"key20251229141312_b79-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1542922","article-title":"Global burden of reported lower respiratory system fungal infection","volume":"15","author":"Wang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"key20251229141312_b80-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/thoraxjnl-2013-203675","article-title":"Significance of halo, reversed halo and air crescent signs in lymphomatoid granulomatosis and pulmonary fungal infections","volume":"68","author":"Srivali","year":"2013","journal-title":"Thorax"},{"key":"key20251229141312_b81-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cmi.2023.08.013","article-title":"Lung and sinus fungal infection imaging in immunocompromised patients","volume":"30","author":"Lamoth","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"key20251229141312_b82-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5152\/ThoracResPract.2023.23013","article-title":"Pulmonary invasive fungal disease: Ultrasound and computed tomography scan findings","volume":"24","author":"Alamdaran","year":"2023","journal-title":"Thorac Res Pract"},{"key":"key20251229141312_b83-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5045\/br.2021.2021127","article-title":"Prophylaxis for invasive fungal infection in pediatric patients with allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Perez","year":"2022","journal-title":"Blood Res"},{"key":"key20251229141312_b84-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/bjh.16329","article-title":"Mucormycosis in children with haematological malignancies is a salvageable disease: A report from the israeli study group of childhood leukemia","volume":"189","author":"Elitzur","year":"2020","journal-title":"Br J Haematol"},{"key":"key20251229141312_b85-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/myc.13222","article-title":"Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases","volume":"64","author":"Bonifaz","year":"2021","journal-title":"Mycoses"},{"key":"key20251229141312_b86-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/17474086.2020.1796624","article-title":"Developments in identifying and managing mucormycosis in hematologic cancer patients","volume":"13","author":"Pagano","year":"2020","journal-title":"Expert Rev Hematol"},{"key":"key20251229141312_b87-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/MPH.0000000000001931","article-title":"Invasive mucormycosis in children with malignancies: Report from the infection working group of the hellenic society of pediatric hematology-oncology","volume":"43","author":"Antoniadi","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"e1011322","key":"key20251229141312_b88-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011322","article-title":"Advances in the treatment of invasive fungal disease","volume":"19","author":"Zhang","year":"2023","journal-title":"PLoS Pathog"},{"issue":"e13611","key":"key20251229141312_b89-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13611","article-title":"Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China assessment of antifungal therapy in hematological diseases (CAESAR) study","volume":"23","author":"Sun","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"1049959","key":"key20251229141312_b90-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1049959","article-title":"Clinical research advances of isavuconazole in the treatment of invasive fungal diseases","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"key20251229141312_b91-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"key20251229141312_b92-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/QCO.0b013e328343614e","article-title":"Amphotericin B in neonates: Deoxycholate or lipid formulation as first-line therapy-is there a \u2018right\u2019 choice?","volume":"24","author":"Turkova","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"key20251229141312_b93-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"key20251229141312_b94-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/myc.13082","article-title":"Treatment of invasive fungal diseases in cancer patients-Revised 2019 recommendations of the infectious diseases working party (AGIHO) of the German society of hematology and oncology (DGHO)","volume":"63","author":"Ruhnke","year":"2020","journal-title":"Mycoses"},{"issue":"18789","key":"key20251229141312_b95-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46328-0","article-title":"Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia","volume":"13","author":"Tu","year":"2023","journal-title":"Sci Rep"},{"key":"key20251229141312_b96-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5045\/br.2017.52.3.167","article-title":"Voriconazole plus caspofungin for treatment of invasive fungal infection in children with acute leukemia","volume":"52","author":"Lee","year":"2017","journal-title":"Blood Res"},{"issue":"e13066","key":"key20251229141312_b97-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13066","article-title":"Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders","volume":"21","author":"Qiu","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"key20251229141312_b98-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5863\/1551-6776-29.4.379","article-title":"A retrospective analysis of micafungin prophylaxis in children under 12 years undergoing chemotherapy or hematopoietic stem cell transplantation","volume":"29","author":"Goscicki","year":"2024","journal-title":"J Pediatr Pharmacol Ther"},{"key":"key20251229141312_b99-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"37","DOI":"10.18502\/CMM.6.2.2840","article-title":"Invasive fungal infections in a pediatric hematology-oncology department: A 16-year retrospective study","volume":"6","author":"Kazakou","year":"2020","journal-title":"Curr Med Mycol"},{"key":"key20251229141312_b100-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.transproceed.2021.04.010","article-title":"Invasive fungal disease among pediatric and adolescent patients undergoing itraconazole prophylaxis after hematopoietic stem cell transplantation","volume":"53","author":"Itsaradisaikul","year":"2021","journal-title":"Transplant Proc"},{"key":"key20251229141312_b101-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s40262-023-01254-2","article-title":"Population pharmacokinetics of posaconazole in immune-compromised children and assessment of target attainment in invasive fungal disease","volume":"62","author":"McCann","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"key20251229141312_b102-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drup.2015.10.001","article-title":"Defining the frontiers between antifungal resistance, tolerance and the concept of persistence","volume":"23","author":"Delarze","year":"2015","journal-title":"Drug Resist Updat"},{"issue":"247","key":"key20251229141312_b103-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2025.13612","article-title":"Antifungal resistance: Emerging mechanisms and implications (Review)","volume":"32","author":"Kadariswantiningsih","year":"2025","journal-title":"Mol Med Rep"},{"key":"key20251229141312_b104-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","article-title":"Drug resistance and tolerance in fungi","volume":"18","author":"Berman","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"key20251229141312_b105-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/jcph.1106","article-title":"Population pharmacokinetics of vancomycin in patients undergoing allogeneic hematopoietic stem-cell transplantation","volume":"58","author":"Okada","year":"2018","journal-title":"J Clin Pharmacol"},{"key":"key20251229141312_b106-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1001\/jama.2019.15702","article-title":"Effect of caspofungin vs fluconazole prophylaxis on invasive fungal disease among children and young adults with acute myeloid leukemia: A randomized clinical trial","volume":"322","author":"Fisher","year":"2019","journal-title":"JAMA"},{"issue":"1800","key":"key20251229141312_b107-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12081800","article-title":"Diagnosis and management of febrile neutropenia in pediatric oncology patients-a systematic review","volume":"12","author":"Boeriu","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"key20251229141312_b108-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1182\/hematology.2021000267","article-title":"Fungal diagnostic testing and therapy: Navigating the neutropenic period in children with high-risk leukemia","volume":"2021","author":"Fisher","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20251229141312_b109-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/INF.0b013e3181e7db7f","article-title":"Risk factors associated with invasive fungal disease in children with cancer and febrile neutropenia: A prospective multicenter evaluation","volume":"29","author":"Villarroel","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"key20251229141312_b110-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.4103\/jcrt.jcrt_1444_22","article-title":"Chinese expert consensus on intestinal microecology and management of digestive tract complications related to tumor treatment (version 2022)","volume":"18","author":"Wang","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"key20251229141312_b111-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.4103\/jcrt.jcrt_32_24","article-title":"Chinese guidelines for integrated diagnosis and treatment of intestinal microecology technologies in tumor application (2024 edition)","volume":"20","author":"Wang","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"key20251229141312_b112-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/INF.0000000000002317","article-title":"Management of invasive fungal disease in neonates and children","volume":"38 (6S Suppl 1)","author":"Ferreras-Antol\u00edn","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"key20251229141312_b113-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00112-021-01146-4","article-title":"Febrile neutropenia in pediatric and adolescent cancer patients","volume":"169","author":"Bochennek","year":"2021","journal-title":"Monatsschr Kinderheilkd"},{"key":"key20251229141312_b114-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jmii.2017.07.005","article-title":"2016 Guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan","volume":"51","author":"Ko","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"issue":"2023-9-2","key":"key20251229141312_b115-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2023-9-2","article-title":"Invasive fungal infections in critically ill children: Epidemiology, risk factors and antifungal drugs","volume":"13","author":"Hon","year":"2024","journal-title":"Drugs Context"},{"key":"key20251229141312_b116-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/17425255.2016.1181752","article-title":"Pharmacokinetic considerations in treating invasive pediatric fungal infections","volume":"12","author":"Goldman","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key20251229141312_b117-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"ii11","DOI":"10.1093\/jac\/dkac352","article-title":"Liposomal amphotericin B-the present","volume":"77 (Suppl 2)","author":"Maertens","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"key20251229141312_b118-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jmii.2012.04.002","article-title":"Innate immune responses to Stenotrophomonas maltophilia in immunocompromised pediatric patients and the effect of taurolidine","volume":"46","author":"H\u00e4rtel","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"key":"key20251229141312_b119-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPH.0000000000001468","article-title":"Frequency and determinants of invasive fungal infections in children with solid and hematologic malignancies in a nonallogeneic stem cell transplantation setting: A narrative review","volume":"41","author":"Ruijters","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"key20251229141312_b120-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cmi.2024.08.006","article-title":"Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies, and management challenges","volume":"31","author":"Giannella","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"833303","key":"key20251229141312_b121-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.833303","article-title":"Dose optimisation of posaconazole and therapeutic drug monitoring in pediatric patients","volume":"13","author":"Jia","year":"2022","journal-title":"Front Pharmacol"},{"key":"key20251229141312_b122-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijantimicag.2014.08.012","article-title":"Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies","volume":"45","author":"Raad","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"key20251229141312_b123-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/17425255.2019.1671971","article-title":"Therapeutic drug monitoring of systemic antifungal agents: A pragmatic approach for adult and pediatric patients","volume":"15","author":"John","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"key20251229141312_b124-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10096-022-04445-0","article-title":"Diagnostic accuracy of the metagenomic next-generation sequencing (mNGS) for detection of bacterial meningoencephalitis: A systematic review and meta-analysis","volume":"41","author":"Kanaujia","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"31658","key":"key20251229141312_b125-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-17392-5","article-title":"Duplex digital PCR assay on microfluidic chamber arrays for total HIV DNA reservoir quantification in persons with HIV","volume":"15","author":"Guti\u00e9rrez-Garc\u00eda","year":"2025","journal-title":"Sci Rep"},{"issue":"116058","key":"key20251229141312_b126-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2024.116058","article-title":"Cascaded amplifying circuit enables sensitive detection of fungal pathogens","volume":"250","author":"Fan","year":"2024","journal-title":"Biosens Bioelectron"},{"key":"key20251229141312_b127-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: An initiative of the European confederation of medical mycology in cooperation with the international society for human and animal mycology and the American society for microbiology","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"3558","key":"key20251229141312_b128-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123558","article-title":"Trichophyton indotineae, an emerging drug-resistant dermatophyte: A review of the treatment options","volume":"13","author":"Sonego","year":"2024","journal-title":"J Clin Med"},{"key":"key20251229141312_b129-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/INF.0000000000002671","article-title":"Isavuconazole as successful salvage therapy for mucormycosis in pediatric patients","volume":"39","author":"Ashkenazi-Hoffnung","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"e0082923","key":"key20251229141312_b130-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00829-23","article-title":"Isavuconazole use and TDM in real-world pediatric practice","volume":"67","author":"Fern\u00e1ndez Ledesma","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"issue":"myac010","key":"key20251229141312_b131-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myac010","article-title":"Clinical characteristics and outcome of invasive fungal sinusitis in children with hematological malignancies","volume":"60","author":"Eissa","year":"2022","journal-title":"Med Mycol"},{"key":"key20251229141312_b132-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1002\/cam4.2395","article-title":"Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials","volume":"8","author":"Egan","year":"2019","journal-title":"Cancer Med"},{"issue":"1316","key":"key20251229141312_b133-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101316","article-title":"Novel insights into fungal infections prophylaxis and treatment in pediatric patients with cancer","volume":"11","author":"Boss\u00f9","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"key20251229141312_b134-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1016\/S1473-3099(21)00203-6","article-title":"Global guideline for the diagnosis and management of rare yeast infections: An initiative of the ECMM in cooperation with ISHAM and ASM","volume":"21","author":"Chen","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"key20251229141312_b135-ETM-31-1-13016","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/myc.12777","article-title":"Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species","volume":"61","author":"Marty","year":"2018","journal-title":"Mycoses"},{"issue":"ofaf555","key":"key20251229141312_b136-ETM-31-1-13016","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf555","article-title":"Rezafungin versus caspofungin for the treatment of candidemia and invasive candidiasis: results from the double-blind, randomized, phase 3 ReSTORE trial including the China extension study","volume":"12","author":"Thompson","year":"2025","journal-title":"Open Forum Infect Dis"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T12:13:17Z","timestamp":1767010397000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2025.13016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":136,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,11,14]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2025.13016","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]}}}